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http://dx.doi.org/10.1016/j.kjms.201Abstract Rapidly progressive glomerulonephritis caused mycobacterium tuberculosis is rare;
however, three case have been reported to date. Crescentic glomerulonephritis is a life-
threatening disease and together with the presence of tuberculous infection is associated with
a poor outcome if treatment is inadequate and delayed. We describe the case of a 31-year-old
female patient with nephrotic syndrome and progressive renal failure secondary to pulmonary
tuberculosis. Renal biopsy showed crescent formation in 14 out of 27 glomeruli, and there was
diffuse linear staining of immunoglobulin G deposits. Treatment included corticosteroids in
combination with antituberculosis drugs for 2 months, and resulted in a significant improve-
ment in renal function, the disappearance of proteinuria and pulmonary symptoms. We also
present a review of the pertinent literature and discuss the pathophysiology of tuberculosis-
related acute postinfectious glomerulonephritis.
Copyright ª 2012, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Historically, various pathogens have been reported to cause
postinfectious glomerulonephritis, including bacteria,rsitesi, Meram Tip Fakultesi,
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hsiung Medical University. Publish
2.10.008viruses, fungi and parasites. [1]. Tuberculosis may be seen in
the urinary system in 4e5% of all cases of extrapulmonary
tuberculosis, and renal involvement may occur by direct
infection of the kidney and/or through secondary amyloid-
osis [2]. The disease usually develops 5e25 years after the
primary tuberculosis infection [3]. Glomerulonephritis
secondary to tuberculosis is uncommon in the group of post-
infectious nephritides [4]. Although several cases ofed by Elsevier Taiwan LLC. All rights reserved.
338 Y. Solak et al.tuberculosis associated with various forms of glomerulone-
phritis have been reported, only three reports of well-
documented crescentic glomerulonephritis associated with
tuberculosis have been published [5e7].
Crescentic glomerulonephritis is potentially life-
threatening and is frequently associated with a rapid clin-
ical deterioration and poor outcome [8]. If treatment is
delayed, patients will develop renal failure within days or
weeks of diagnosis [9,10]. The presence of tuberculosis
associated with progressive glomerulonephritis complicates
the choice and sequence of therapeutic options of immuno-
suppressive agents and/or anti-tuberculosis drugs. It is very
important to make an early diagnosis of nephropathy asso-
ciated with tuberculosis and to start appropriate treatment.
We report on a patient with crescentic glomerulonephritis
secondary to pulmonary tuberculosis in which antitubercu-
losis treatment ameliorated renal function. We also discuss
the related cases reported in the literature.
Case report
A 31-year-old female patient presenting with uremia, fever,
fatigue, and productive cough was admitted into the
nephrology ward with suspicion of contrast-induced
nephropathy. Two weeks before admission, the patient
had undergone appendectomy for perforated appendicitis,
and after the operation abdominal computed tomography
(CT) was performed in order to search for an intra-
abdominal abscess. Initially the patient had normal kidney
function and she had no prior history of renal or pulmonary
disease. She said that her mother had a history of tuber-
culosis. There was no palpable lymphadenopathy and pre-
tibial edema. On pulmonary auscultation, there were
rhonchi in the middle zone of the left lung. Blood pressure
was 130/80 mmHg and examination of the cardiovascular,
gastrointestinal and urogenital systems were unremark-
able. Urine output was 3600 mL/24 h on the first day of
admission. Laboratory examination showed hemoglobin
10.7 g/dL, hematocrit 37.2%, white blood cell count
11,000/mm3, platelets 298  103/mL, erythrocyte sedi-
mentation rate 41 mm/h, C-reactive protein 68.5 mg/dL,
blood urea nitrogen (BUN) 81 mg/dL, serum creatinine
5.7 mg/dL (glomerular filtration rate 9.2 mL/min byFigure 1. (A) Light microscopy of the renal biopsy shows a cellu
eosin staining, magnification 100). (B) Direct immunofluorescen
deposits (magnification 200).modification of diet in renal disease formula), potassium
6.0 mEq/L, serum albumin 2.8 g/dL, total protein 6.17 mg/
dL, and activated partial thromboplastin time 26.8 seconds.
Urine analysis yielded 3þ erythrocytes on strip and
proteinuria 75 mg/dL. Twenty-four-hour urine collection
showed protein excretion 9.8 g/24 h, urine microalbumin
1980 mg/24 h, urine creatinine 1204 mg/24 h and creatinine
clearance of 17.4 mL/min. Renal ultrasonography showed
bilateral kidneys with normal size and shape, but increased
parenchymal echogenicity. Markers for immune-associated
nephrites [antinuclear antibodies (ANA), antineutrophil
cytoplasmic antibodies (ANCA), anti-dsDNA, antiglomerular
basement membrane (GBM) antibody] were negative. Renal
biopsy showed crescent formation in 14 out of 27 glomeruli
and there was diffuse linear staining of immunoglobulin G
deposits (Fig. 1). There were no granulomas and Langhans’
giant cells. The sputum and urine culture produced
a negative result for mycobacterium tuberculosis. A chest
X-ray image showed bilateral upper lobe opacities
compatible with pneumonic consolidations, which was
more prominent in the left lung (Fig. 2A). Chest CT
confirmed this pneumonic consolidation (Fig. 3). We diag-
nosed pulmonary tuberculosis based on the findings of chest
CT and examination of sputum, which was positive for
acido-resistant bacilli (ARB). Considering the presence of
nephrotic syndrome and crescent formation, we started
intravenous methylprednisolone pulses of 500 mg/day for 3
days, and then methylprednisolone was continued orally at
a dose of 64 mg/day. Four-drug antituberculosis treatment
was also administered after having seen ARB positivity.
After 2 months of immunosuppressive and antituberculosis
therapy, renal function repaired, plasma creatinine level
decreased from 5.7 mg/dL to 1.4 mg/dL and the pulmonary
symptoms also responded to the treatment (Fig. 2B). The
clinical course of the patient during her hospitalization is
illustrated in Fig. 4.
Discussion
Acute postinfectious glomerulonephritis (APIG) is
uncommon in adults and its incidence continues to decline
thanks to early and more effective therapies of infections.
In a recent series by Nasr et al. [11], the most commonlar crescent (arrow) in one of the glomeruli (hematoxylin and
ce image shows diffuse linear staining of immunoglobulin G
Figure 2. (A) Chest X-ray film on admission. Bilateral upper lobe opacities are compatible with pneumonic consolidations, and is
more prominent in the left lung. (B) Reduction of this consolidation after 7 weeks.
Figure 3. (A, B) Bilateral pneumonic consolidations that are more prominent on the left, in both lungs in axial sections of chest
computed tomography.
Glomerulonephritis associated with tuberculosis 339pathogens were staphylococci and streptococci. The most
common renal histologic pattern related to APIG was
diffuse endocapillary proliferative and exudative glomeru-
lonephritis, while crescent formation was only present inFigure 4. Clinical course of the patient during hospitalization. AB
cytoplasmic antibodies, Anti-GBM e anti-glomerular basement me
tomography, CI-AKI e contrast induced acute kidney injury, CRP e C
RPGN e rapidly progressive glomerulonephritis, TB e tuberculosis.four out of 86 patients [11]. On immunofluorescence
microscopy, in 82% of cases the granular staining was seen
as the most common pattern in the mesangium and
glomerular capillary wall [11].– antibodies, ANA – antinuclear antibodies, ANCA – antineutrophil
mbrane, ARB e acido-resistant bacilli, CCT e Chest computed
-reactive protein, CXR e Chest X-ray, GN – glomerulonephritis,
340 Y. Solak et al.Important points when making a diagnosis of APIG are:
evidence of infection preceding the glomerulonephritis,
glomerular change consistent with postinfectious glomeru-
lonephritis; and the absence of systemic disease that can
account for the glomerular changes. The favorable
response to anti-infection therapy also supports the diag-
nosis of APIG [12].
Tuberculosis can cause renal disease in a number of
ways. The most common form is genitourinary tuberculosis
via direct invasion by the bacilli. Chronic interstitial
nephritis and amyloidosis are among the other forms that
may develop [4]. Usually, renal involvement in tuberculosis
histologically consists of epithelioid granuloma, with or
without caseation, and often contains Langhans-type giant
cells [4]. However, glomerulonephritis associated with
tuberculosis infection is very rare. To the best of ourTable 1 Overview of previous cases of tuberculosis associated
First author
(year)
Patient
details
Clinical features Proteinuria
Shribman JH,
(1983)
45 years,
male
Fever, weight loss, HT 1.3 g/24 h
Cohen AJ,
(1985)
59 years,
male
Microscopic hematuria,
casts,
negative
Meyrier A,
(1988)
46 years,
male
Hematuria, edema and
HT
8.0 g/24 h
O’Brien AA
(1990)
63 years,
male
Nephrotic syndrome 3.9 g/24 h
Sopena B,
(1991)
55 years,
male
Fever, cough, HT,
edema and oligouria
0.7 g/24 h
De Siati L,
(1999)
31 years,
male
Fever, macroscopic
hematuria, oligouria
mean,
5.13 g/L
Matsuzawa N,
(2002)
35 years,
female
Edema, fever, pleural
effusion, abdominal
pain
5.6 g/24 h
Keven K,
(2004)
36 years,
male
Dyspnoea, cough,
haematuria and edema
6.8 g/24 h
Coventry S,
(2004)
16 years,
female
Anasarca 27.9 g/24 h
Fofi C,
(2005)
75 years,
male
Purpura, anemia,
oliguria and hematuria
6.0 g/24 h
Wen YK,
(2009)
70 year,
male
Caugh, cervical
lymphadenopathy, HT
and edema
0.6 g/24 h
Singh P,
(2009)
34 years,
male
Fever, weight loss,
erythrocyturia
2.04 mg/dL
Yuan Q,
(2010)
50 years,
female
Fever, weight loss,
low-back pain,
hematuria
2.6 g/24 h
Ortmann J,
(2010)
36 years,
male
Pleural effusions,
erythrocyturia, and HT
Proteinuria (?)
Our Case
(2011)
31year,
female
Uremia, fever,
fatigability and
productive cough
9.8 g/24 h
ATD e anti-tuberculous drugs, CGN e crescentic glomerulonephritis, C
tuberculosis, FSGS e focal-segmental glomerulosclerosis, HD e hemod
tuberculosis, MCGN e mesangio-capillary glomerulonephritis, MGN e
MPGN e mesangio-proliferative glomerulonephritis, MT e miliary tu
pleuro-pulmonary tuberculosis, PT e pulmonary tuberculosis.knowledge, 14 cases in which tuberculosis was associated
with different forms of glomerulonephritis have been re-
ported in the literature (Table 1). Histopathological
changes were consistent with immunoglobulin A (IgA)
nephropathy in six cases [13e18], mesangioproliferative
glomerulonephritis in two cases [19,20], one case of each of
collapsing glomerulopathy [21], mesangiocapillary [22] and
membranous glomerulonephritis [23], and three cases of
crescentic glomerulonephritis [5e7].
IgA nephropathy is the most commonly encountered histo-
logical subtype of tuberculosis associated glomerulonephritis
(TAG). Recent data have started to unveil the basic patho-
physiologicalmechanismof this predilection. It is awell known
fact that immune response to mycobacterial infection is
primarily cell mediated. The role of humoral immune system,
however, has beendemonstrated including thepresence of IgAglolomerulonephritis reported in the literature.
GFR or
creatinine
Type
of TBC
Renal
biopsy
Treatment
options
Treatment
outcome
2.9 mg/dL MT MPGN ATD and CS Responded
1.2 mg/dL DT IgAN ATD Responded
55 ml/min DT MCGN ATD and
NSAID
Responded
Normal PT MPGN ATD Responded
18 mg/dL PT CGN ATD, CS,
CP and HD
Responded
32 ml/min PT IgAN ATD Responded
Normal DT IgAN ATD Responded
116 ml/min PT IgAN ATD Responded
z80 ml/min PT FSGS CS, ATD
and MMF
Progressed
to ESRD
60 ml/min PT CGN
and IgAN
ATD and HD Patient died
Less than
10 ml/min
MT CGN ATD and HD Responded
Normal PPT IgAN ATD Responded
27 ml/min LT MGN ATD and CS Responded
1.9 mg/dL PPT IgAN ATD Partial
remission
17.4 ml/min PT CGN ATD and CS Responded
P e cyclophosphamide, CS e corticosteroids, DT e disseminated
ialysis, HT e hypertension, IgAN e IgA nephropathy, LT e lumbar
membranous glomerulonephritis, MMF e mycophenolate mofetil,
berculosis, NSAID e nonsteroid anti-inflammatory drugs, PPT e
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complexesandmycobacterial antigens in theserumofpatients
with active tuberculosis [24]. Thus, acute tuberculous infec-
tion is associated with a marked increase in serum IgA levels.
Deposition of these complexes in turn may activate the alter-
native complement [25] and the lectin pathway [26], with
resultant local injury leading to IgA nephropathy. These
preliminary observations may account for the dominance of
the IgA nephropathy subtype of TAG.
It is arguable, however, whether every patient with
renal tuberculosis develops IgA nephropathy and thus
requires a renal biopsy to document the diagnosis. Obvi-
ously only a very small subset of patients with renal
tuberculosis presents with IgA nephropathy. On the other
hand, we should bear in mind that in the case of proteinuria
along with hematuria and sterile pyuria, renal biopsy may
be needed to diagnose concurrent IgA nephropathy.
In 12 cases out of 14, renal function was ameliorated
following anti-tuberculosis therapy. One patient with extrac-
apillary IgA nephropathy died [7] and another patient
developed end-stage renal disease [21]. All patients with
rapidly-progressive glomerulonephritis underwent hemodial-
ysis therapy, and in one case treatment was combined with
immunosuppressive drugs [5]. Two patients with crescentic
glomerulonephritis responded to therapy and renal function
was restored at the end of the therapy [5,6]. In another case,
the patient who did not receive corticosteroids because of
contraindications died despite anti-tuberculous therapy. The
unsuccessful result in this casewas considered to be related to
the older age of the patient with a long history of hyperten-
sion, rifampicin nephrotoxicity, diffuse intra- and extracapil-
lary proliferation with cellular crescents and glomerular
sclerosis, severe anemia and steady oliguria [7].
Immune-complex crescentic glomerulonephritis (ICCG) is
oneofthree formsofcrescenticglomerulonephritis; theothers
are pauci-immune and linear deposition [27]. We could not
detectanti-GBMorANCAantibodies inourpatient. ICCGcanbe
seen in a number of primary glomerulonephritides including
IgA nephropathy, membranous and membranoproliferative
glomerulonephritides, and as a result of infection.
In our case, renal functional impairment was already
present at the initial presentation. However, the patient did
not require renal replacement therapy during the course of
hospitalization as she was not oliguric, so we preferred to
wait. She had nephrotic syndrome and uremia, consistent
with the cases reported in the literature. The patient also had
fever, cough, purulent sputum, constitutional symptoms,
pulmonary infiltrates and nodules on imaging studies. Our
primary concern was a pulmonary renal syndrome; however,
serological disease markers were found to be negative. After
ARB were seen on expectorated sputum, a diagnosis of
pulmonary tuberculosis was established. ICCGwas thought to
be secondary to pulmonary tuberculosis infection. Ameliora-
tion of kidney function with a four-drug anti-tuberculosis
regimen further supported our initial diagnosis.
Additionally, a similar clinical and radiographical picture
of pulmonary tuberculosis may show non-tuberculosis
mycobacterium (NTM) infection. Chen et al. [28] reported
a single case of NTM infection associated with rapidly
progressive glomerulonephritis. Pulmonary symptoms and
renal function steadily improved after initiation of anti-
NTM therapy. Diagnosis of pulmonary NTM infection isdifficult. NTM are widely dispersed in our environment and
there are more than 20 species of NTM. Unlike tuberculosis,
NTM are not spread from human to human. Clinical,
radiographic, and microbiological criteria include pulmo-
nary symptoms, radiographic opacities, nodular or cavitary
pneumonia, or multifocal bronchiectasis with multiple
small nodules and a thrice positive microbiological culture
of mycobacterium other than tuberculosis [29]. In our
patient, three sputum cultures were negative for any form
of tuberculosis.
When acute postinfectious glomerulonephritis develops
and is related to tuberculosis, immune complex deposition
also occurs in the form of a granular pattern [5,6]. In our
case, however, it was linear. At this point, we may argue
that our patient had anti-GBM antibody disease with cres-
cent formation. The anti-GBM antibody test was negative,
however, and the patient did not have pulmonary hemor-
rhage. Furthermore, her kidney function ameliorated
without plasmapheresis. This latter situation argues against
anti-GBM antibody disease, as it is unusual that such
a patient presenting with high serum creatinine would
completely recover from renal dysfunction.
In conclusion, ICCG has rarely been reported in the
literature. It should be suspected in a patient with rapidly-
deteriorating kidney function in the setting of pulmonary or
disseminated tuberculosis infection.References
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